We are live on ! Find out more
COCP icon

Cocrystal Pharma
COCP

33 hedge funds and large institutions have $5.83M invested in Cocrystal Pharma in 2022 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 7 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

0.01% less ownership

Funds ownership: 1.23% → 1.22% (-0.01%)

3% less funds holding

Funds holding: 34 → 33 (-1)

14% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 7

26% less capital invested

Capital invested by funds: $7.9M → $5.83M (-$2.08M)

43% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 7

Holders
33
Holders Change
-1
Holders Change %
-2.94%
% of All Funds
0.56%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
6
Increased
4
Reduced
7
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SM
Sabby Management
Florida
+$123K
2
TRCT
Tower Research Capital (TRC)
New York
+$7.7K
3
Jane Street
Jane Street
New York
+$6.59K
4
TSS
Two Sigma Securities
New York
+$5.67K
5
Goldman Sachs
Goldman Sachs
New York
+$5.66K

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$98.7K
2
Morgan Stanley
Morgan Stanley
New York
-$79.8K
3
RJFSA
Raymond James Financial Services Advisors
Florida
-$13K
4
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$9K
5
VF
Virtu Financial
New York
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
SM
1
Sabby Management
Florida
$2.41M +$123K +23,074 +5%
Vanguard Group
2
Vanguard Group
Pennsylvania
$1.33M -$7.79K -1,463 -0.5%
Renaissance Technologies
3
Renaissance Technologies
New York
$698K -$927 -174 -0.1%
BlackRock
4
BlackRock
New York
$364K -$98.7K -18,522 -20%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$331K +$3.9K +733 +1%
Morgan Stanley
6
Morgan Stanley
New York
$220K -$79.8K -14,976 -25%
State Street
7
State Street
Massachusetts
$120K – – –
PA
8
Parallel Advisors
California
$75K – – –
Verition Fund Management
9
Verition Fund Management
Connecticut
$66K – – –
Northern Trust
10
Northern Trust
Illinois
$59K – – –
Bank of America
11
Bank of America
North Carolina
$44K – – –
Bank of New York Mellon
12
Bank of New York Mellon
New York
$18K – – –
BJL
13
Brighton Jones LLC
Washington
$11K – – –
TRCT
14
Tower Research Capital (TRC)
New York
$11K +$7.7K +1,445 +206%
Commonwealth Equity Services
15
Commonwealth Equity Services
Massachusetts
$10K – – –
WWM
16
Western Wealth Management
Colorado
$10K – – –
BRWA
17
B. Riley Wealth Advisors
Florida
$6K – – –
Jane Street
18
Jane Street
New York
$6K +$6.59K +1,237 New
Victory Capital Management
19
Victory Capital Management
Texas
$5K -$37 -7 -0.7%
HF
20
HRT Financial
New York
$5K +$5.55K +1,042 New
Goldman Sachs
21
Goldman Sachs
New York
$5K +$5.66K +1,062 New
TSS
22
Two Sigma Securities
New York
$5K +$5.67K +1,064 New
JP Morgan Chase
23
JP Morgan Chase
New York
$3K -$884 -166 -19%
CYG
24
Clean Yield Group
Vermont
$2K – – –
UBS Group
25
UBS Group
Switzerland
$1K -$7.45K -1,398 -92%
1
2

COCP Hedge Fund Activity: Q2 2022 in Review

33 of the 5,936 institutional investors tracked by Wall St. Rank reported a position in Cocrystal Pharma (COCP) for Q2 2022, worth a combined $5.83M — down 26% from $7.9M a quarter earlier.

Sellers outnumbered buyers: 7 funds closed out of COCP and 6 opened new positions — a net loss of 1 holder — while 7 trimmed existing stakes and 4 added.

The largest buyer was Sabby Management, adding an estimated $123K. The largest seller was BlackRock, cutting an estimated $98.7K.

  • 33 institutional investors held Cocrystal Pharma (COCP) as of Q2 2022, down from 34 in Q1 2022.
  • Funds reported $5.83M of Cocrystal Pharma stock for Q2 2022, down 26% quarter-over-quarter.
  • 6 funds opened new Cocrystal Pharma positions in Q2 2022 and 7 closed out, a net change of -1 holder.
  • The largest Cocrystal Pharma buyer in Q2 2022 was Sabby Management, an estimated $123K added.
  • The largest Cocrystal Pharma seller in Q2 2022 was BlackRock, an estimated $98.7K sold.

Based on aggregated 13F filings for Q2 2022.